Methods of treating cystic fibrosis transmembrane conductance regulator (cftr) dysfunction
AssigneeNational Jewish Health
InventorsPreston E. Bratcher, Pamela L. Zeitlin
Life of this patent
Estimating the term…
Abstract
Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
Claims33
A method of treating a cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease in a patient, comprising administering to the patient an effective amount of a CFTR activator or a pharmaceutically acceptable salt thereof.
(canceled)
(canceled)
(canceled)
A method of treating a cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease in a patient, comprising administering to a patient who is receiving treatment with a CFTR potentiator and/or CFTR corrector, an effective amount of a CFTR activator or a pharmaceutically acceptable salt thereof.
-36. (canceled)
Dependencies are inferred from the claim text.